An algorithm for simplified hepatitis C virus treatment with non-specialist care based on nation-wide data from Taiwan.
Ming-Lung YuChi-Ming TaiLein-Ray MoHsing-Tao KuoChung-Feng HuangKuo-Chih TsengChing-Chu LoMing-Jong BairSzu-Jen WangJee-Fu HuangMing-Lun YehChun-Ting ChenMing-Chang TsaiChien-Wei HuangPei-Lun LeeTzeng-Hue YangYi-Hsiang HuangLee-Won ChongChien-Lin ChenChi-Chieh YangChao-Hung HungSheng-Shun YangPin-Nan ChengTsai-Yuan HsiehJui-Ting HuWen-Chih WuChien-Yu ChengGuei-Ying ChenGuo-Xiong ZhouWei-Lun TsaiChien-Neng KaoChih-Lang LinChia-Chi WangTa-Ya LinChih-Lin LinWei-Wen SuTzong-Hsi LeeTe-Sheng ChangChun-Jen LiuChia-Yen DaiChi-Yi ChenJia-Horng KaoHan-Chieh LinWan-Long ChuangCheng-Yuan PengPublished in: Hepatology international (2024)
Real-world data from Taiwan confirmed that simplified HCV treatment for eligible patients with pan-genotypic regimens is effective and well tolerated. The TACR algorithm, developed based on this study's results, can further identify patients who can be safely managed by non-specialist care.